Gennex Laboratories (BOM:531739) Dividend Yield %: 0.00% (As of Jul. 04, 2026)


BOM:531739 Gennex Laboratories Ltd BOM:531739
81 GF Score
Price ₹10.16
GF Value ₹15.43
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Gennex Laboratories Dividend Yield %?

Gennex Laboratories BOM:531739 -1.74% 81 Dividend Yield % is 0.00% as of Jul. 04, 2026. GuruFocus rates BOM:531739 with a GF Score™ of 81/100 and a GF Value™ of ₹15.43 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 518 Drug Manufacturers companies, Gennex Laboratories ranks worse than 193050% on this metric.

As of today (2026-07-04), the Trailing Annual Dividend Yield of Gennex Laboratories is 0.00%.

The historical rank and industry rank for Gennex Laboratories's Dividend Yield % or its related term are showing as below:

BOM:531739's Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.95
* Ranked among companies with meaningful Dividend Yield % only.

Gennex Laboratories's Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00.

As of today (2026-07-04), the Forward Dividend Yield % of Gennex Laboratories is 0.00%.

Gennex Laboratories's Dividends per Share for the three months ended in Mar. 2026 was ₹0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Gennex Laboratories  (BOM:531739) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Gennex Laboratories Dividend Yield % Related Terms


Gennex Laboratories Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Gennex Laboratories's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gennex Laboratories Dividend Yield % Chart

Gennex Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Gennex Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOM:531739 vs ZTS, UTHR: Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gennex Laboratories's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennex Laboratories Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gennex Laboratories's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Gennex Laboratories's Dividend Yield % falls into.


BOM:531739
81GF Score
Gennex Laboratories Ltd BOM:531739
Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gennex Laboratories Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Gennex Laboratories (BOM:531739) has a Dividend Yield % of 0.00% as of Jul. 04, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Gennex Laboratories and its competitors. According to the industry distribution chart, Gennex Laboratories ranks #999999 out of 518 companies in the Drug Manufacturers industry.
Is Gennex Laboratories' Dividend Yield % too high?
Gennex Laboratories' current Dividend Yield % is 0.00%. Based on the distribution chart, Gennex Laboratories ranks #999999 out of 518 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Gennex Laboratories has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gennex Laboratories' Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gennex Laboratories ranks #999999 out of 518 companies for Dividend Yield %. This places Gennex Laboratories in the lower half of its industry. The industry median Dividend Yield % is 1.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.95, based on 518 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Gennex Laboratories and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gennex Laboratories's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gennex Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Gennex Laboratories (BOM:531739) is currently considered Possible Value Trap. The stock's GF Value™ is ₹15.43, compared to a current price of ₹10.16 — trading 34.2% below its estimated fair value. The current Dividend Yield % is 0.00%. Gennex Laboratories' overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Gennex Laboratories (BOM:531739), the current Dividend Yield % is 0.00% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹10.16 is trading 34.2% below its estimated GF Value™ of ₹15.43. GuruFocus considers Gennex Laboratories to be Possible Value Trap.

Key valuation signals for BOM:531739:

  • Dividend Yield %: 0.00%
  • GF Value™: ₹15.43 vs. price of ₹10.16 (34.2% below fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
81GF Score

Get the complete analysis for BOM:531739

Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹10.16
Price
₹15.43
GF Value